The DOI matches its Crossref record.
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Minocycline, nitrofurantoin, methyldopa, and infliximab are the most commonly implicated drugs in DI-ALH.
“Minocycline, nitrofurantoin, methyldopa, and infliximab are the most commonly implicated drugs”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [32]
There is very limited data on the dose of corticosteroids used to treat DI-ALH in the published literature.
“There is very limited data on the dose of corticosteroids used to treat DI-ALH in the published literature.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 25
- Suzuki, 2011, The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury, Hepatology, 54, 931, 10.1002/hep.24481 · DOI · Paper page
- Navarro, 2006, Drug-related hepatotoxicity, New England Journal of Medicine, 354, 731, 10.1056/NEJMra052270 · DOI · Paper page
- Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Annals of Internal Medicine, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
- Wei, 2007, Acute liver failure in Sweden: etiology and outcome, Journal of Internal Medicine, 262, 393, 10.1111/j.1365-2796.2007.01818.x · DOI
- Björnsson, 2010, Drug-induced autoimmune hepatitis: clinical characteristics and prognosis, Hepatology, 51, 2040, 10.1002/hep.23588 · DOI · Paper page
- Germano, 2005, Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis, Annals of the Rheumatic Diseases, 64, 1519, 10.1136/ard.2004.032821 · DOI
- Wolters, 2005, Rosuvastatin-associated hepatitis with autoimmune features, European Journal of Gastroenterology and Hepatology, 17, 589, 10.1097/00042737-200505000-00019 · DOI
- Kamiyama, 1997, Autoimmune hepatitis triggered by administration of an herbal medicine, American Journal of Gastroenterology, 92, 703
- Licata, 2013, Herbal hepatotoxicity: a hidden epidemic, Internal and Emergency Medicine, 8, 13, 10.1007/s11739-012-0777-x · DOI
- Czaja, 2011, Drug-induced autoimmune-like hepatitis, Digestive Diseases and Sciences, 56, 958, 10.1007/s10620-011-1611-4 · DOI · Paper page
- Fontana, 2010, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop, Hepatology, 52, 730, 10.1002/hep.23696 · DOI
- Aithal Gp, 2011, Case definition and phenotype standardization in drug-induced liver injury, Clinical Pharmacology and Therapeutics, 89, 806, 10.1038/clpt.2011.58 · DOI · Paper page
- Weiler Normann, 2011, Drug-induced liver injury and its relationship between to autoimmune hepatitis, Journal of Hepatology, 55, 747, 10.1016/j.jhep.2011.02.024 · DOI · Paper page
- Hennes, 2008, Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, 169, 10.1002/hep.22322 · DOI · Paper page
- Macaluso, 2014, Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C, Journal of Hepatology, 61, 523, 10.1016/j.jhep.2014.04.045 · DOI
- Di Marco, 2011, Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis, Gut, 60, 1023, 10.1136/gut.2010.228478 · DOI
- Lucena, 2011, Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish registry: the dilemma of the relationship with autoimmune hepatitis, Journal of Hepatology, 55, 820, 10.1016/j.jhep.2010.12.041 · DOI · Paper page
- Qiu, 2003, Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients, Journal of Gastroenterology and Hepatology, 18, 63, 10.1046/j.1440-1746.2003.02918.x · DOI
- Goldberg, 2001, Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus, Human Immunology, 62, 165, 10.1016/S0198-8859(00)00234-2 · DOI
- Oliveira, 2011, Autoimmune hepatitis, HLA and extended haplotypes, Autoimmunity Reviews, 10, 189, 10.1016/j.autrev.2010.09.024 · DOI
- Lucena, 2011, Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles, Gastroenterology, 141, 338, 10.1053/j.gastro.2011.04.001 · DOI · Paper page
- Donaldson, 2010, Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury, Journal of Hepatology, 53, 1049, 10.1016/j.jhep.2010.05.033 · DOI
- Daly, 2009, HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin, Nature Genetics, 41, 816, 10.1038/ng.379 · DOI
- Manns, 2010, Diagnosis and management of autoimmune hepatitis, Hepatology, 51, 2193, 10.1002/hep.23584 · DOI · Paper page
- vanGerven, 2013, Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission, Journal of Hepatology, 58, 141, 10.1016/j.jhep.2012.09.009 · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Devarbhavi, H., Aithal, G., Treeprasertsuk, S., Takikawa, H., Mao, Y., Shasthry, S. M., Hamid, S., Tan, S. S., Philips, C. A., George, J., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10144-3 · Cited by 181
Andrade, R. J., Aithal, G. P., de Boer, Y. S., Liberal, R., Gerbes, A., Regev, A., Terziroli Beretta-Piccoli, B., Schramm, C., Kleiner, D. E., De Martin, E., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.033 · Cited by 166
Self-citation
Metadata
- Authors
- Licata, A., Maida, M., Cabibi, D., Butera, G., Macaluso, F. S., Alessi, N., Caruso, C., Craxì, A., & Almasio, P. L.
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 46
- Issue
- 12
- Pages
- 1116-1120
- ISSN
- 1590-8658
- Cited by
- 59
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
